Vikas Lifecare Ltd (VIKASLIFE) — shareholding pattern, promoter holding, financials and share price

About Vikas Lifecare Ltd (VIKASLIFE)

Vikas Lifecare Ltd operates in the Trading & Distributors industry, within the Services sector. It trades on the NSE as VIKASLIFE and on the BSE under scrip code 542655. Its ISIN is INE161L01027.

Incorporated in 1995, Vikas Lifecare Ltd is under four business segments which is trading(Base polymers, additives and chemicals meant for plastic processing, commodity compounds( Manufacturing up-cycled polymer compounds like EVA, PVC, PP,PE etc.), Environment protection( Recycling and up-cycling of plastic waste to fulfill EPR) and FMCG & Healthcare which can be further divided into different major segments which include Smart product Business( Smart gas and water meters), Polymer & Chemical Business (Recycling materials, trading and manufacturing of Polymer Compounds), FMCG segment (Agro Product), Infra Products( Steel fittings & Steel Bars), Food grade piping system for Jal Jeevan Mission. [1]

Vikas Lifecare Limited operates in recycling plastic waste and manufacturing polymer compounds. Initially focused on trading polymer compounds, it has transitioned to manufacturing after acquiring a division from Vikas Ecotech Limited.

The company has diversified its portfolio beyond B2B raw materials to include B2C segments such as FMCG, Agro, and Infrastructure Products, and recently textiles and garments.

Listed peers in Trading & Distributors: Vega Jewellers Ltd, Sakuma Exports Ltd, Integra Essentia Ltd, Sicagen India Ltd, Chandrima Mercantiles Ltd, Northern Spirits Ltd.

Valuation & Returns

10 Jul 2026

At ₹1.39 a share on 10 Jul 2026, Vikas Lifecare Ltd (VIKASLIFE) was valued at a price-to-earnings ratio of 13.9x against an industry P/E of 21.24x and a price-to-book of 0.49x on a book value of ₹2.86 per share as of Mar 2025. Solomo computes return on equity of -20.8% and return on capital employed of -18.96% from filed results. Earnings ratios use consolidated results for the twelve months Jun 2025 to Mar 2026.

P/E
13.9x
Industry P/E
21.24x
P/B
0.49x
EPS (TTM)
₹-0.6
Book value / share
₹2.86
ROE
-20.8%
ROCE
-18.96%
ROA
-15.16%
Debt / equity
0.14x
Dividend yield
0%
EBITDA margin
3.92%
52-week range
₹1.05 – ₹2.61

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Vikas Lifecare Ltd (VIKASLIFE) reported revenue of ₹499 crore, net profit of ₹18 crore and earnings per share of ₹0.1. That compares with revenue of ₹480 crore and net profit of ₹-11 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹169 crore and net profit ₹42 crore (consolidated).

Consolidated annual results for Vikas Lifecare Ltd (VIKASLIFE), Mar 2022 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Revenue (₹ cr)301476446480499
Net profit (₹ cr)29-1613-1118
EPS (₹)0.26-0.110.09-0.060.1
Compound annual growth for Vikas Lifecare Ltd (VIKASLIFE). Stock price CAGR is price return and excludes dividends.
Measure10Y5Y3Y1Y
Sales growth19.49%24.32%16.26%7.50%
Profit growth----181.19%
Stock price CAGR--18%-25%-47%

Ownership Summary

Mar 2026

As of Mar 2026, promoters hold 14.2% of Vikas Lifecare Ltd (VIKASLIFE) (unchanged from the previous quarter), foreign institutional investors (FII) hold 0.26% and domestic institutional investors (DII) hold 0%. Market capitalisation was ₹258 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Jun 2019.

Largest disclosed public shareholders in Mar 2026: SRESTHA FINVEST LIMITED 1.97%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Mar 202614.2%-0.26%0%85.8%
Dec 202514.2%-0.28%0%85.8%
Sep 202514.2%-0.3%0%85.8%
Jun 202514.2%-0.38%0%85.8%
Mar 202514.2%-0.46%0%85.8%
Dec 202414.2%-0.49%0%85.8%
Sep 202414.2%-0.5%0%85.8%
Jun 202414.21%-0.28%0%85.79%
Every quarter since Jun 2019 Filing data, not investment advice.